Chiang G G, Wooten D C, Dilley R A
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907.
Biochemistry. 1992 Jun 30;31(25):5808-19. doi: 10.1021/bi00140a017.
Earlier work suggested that Ca2+ ions in the chloroplast thylakoid lumen interact with thylakoid membrane proteins to produce a proton flux gating structure which functions to regulate the expression of the energy-coupling H+ gradient between localized and delocalized modes [Chiang, G., & Dilley, R. A. (1987) Biochemistry 26, 4911-4916]. In this work, one of the phenothiazine Ca2+ antagonists, chlorpromazine, was used as a photoaffinity probe to test for Ca(2+)-dependent binding of the probe to thylakoid proteins. [3H]Chlorpromazine photoaffinity-labels thylakoid polypeptides of Mr 8K and 6K, with generally much less label occurring in other proteins (some experiments showed labeled proteins at Mr 13K-15K). More label was incorporated in circumstances where it is expected that Ca2+ occupies the putative H+ flux gating site, compared to when the gating site is not occupied by calcium. The photoaffinity labeling of the 8-kDa protein was also influenced by the energization level of the thylakoids (less labeling under H+ uptake energization). The 8-kDa protein was identified by partial amino acid sequence data as subunit III of the thylakoid CF0 H+ channel complex. The partial amino acid sequence of the 6-kDa protein (19 residues were determined with some uncertainties) was compared to data in the GCG sequence analysis data base, and no clear identity to a known sequence was revealed. Neither the exact site of putative Ca2+ binding to the CF0 proteolipid nor the site of covalent attachment of the chlorpromazine to the CF0 component has been identified. Evidence for gating of energy-linked H+ fluxes by the hypothesized Ca(2+)-CF0 gating site came from the correlation between Ca(2+)-dependent binding of chlorpromazine to the CF0 8-kDa protein with inhibition of light-driven H+ uptake into the lumen but no inhibition of H+ uptake into sequestered membrane domains. When conditions favored a delocalized delta mu H+ coupling mode, less chlorpromazine was bound to the CF0 structure, and much larger amounts of H+ ions were accumulated in the lumen. The data support the hypothesis that Ca2+ ions act in concert with the 8-kDa CF0 protein (and perhaps another protein, the 6-kDa polypeptide?) in a gating mechanism for regulating the expression of the energy-coupling H+ gradient between localized or delocalized coupling modes.
早期研究表明,叶绿体类囊体腔中的Ca2+离子与类囊体膜蛋白相互作用,形成质子通量门控结构,该结构的作用是调节局部和离域模式之间能量耦合H+梯度的表达[蒋,G.,&迪利,R. A.(1987年)《生物化学》26,4911 - 4916]。在本研究中,一种吩噻嗪类Ca2+拮抗剂氯丙嗪被用作光亲和探针,以检测该探针与类囊体蛋白的Ca(2+)依赖性结合。[3H]氯丙嗪对Mr为8K和6K的类囊体多肽进行光亲和标记,其他蛋白质中的标记通常要少得多(一些实验显示在Mr为13K - 15K处有标记蛋白)。与门控位点未被钙占据时相比,在预期Ca2+占据假定的H+通量门控位点的情况下,有更多的标记被掺入。8 kDa蛋白的光亲和标记也受类囊体的能量化水平影响(在H+摄取能量化条件下标记较少)。通过部分氨基酸序列数据鉴定出8 kDa蛋白为类囊体CF0 H+通道复合物的亚基III。将6 kDa蛋白的部分氨基酸序列(确定了19个残基,存在一些不确定性)与GCG序列分析数据库中的数据进行比较,未发现与已知序列有明确的一致性。尚未确定假定的Ca2+与CF0质子脂质结合的确切位点,也未确定氯丙嗪与CF0组分的共价连接位点。关于假定的Ca(2+) - CF0门控位点对能量相关H+通量的门控作用的证据来自于氯丙嗪与CF0 8 kDa蛋白的Ca(2+)依赖性结合与光驱动的H+摄取到腔中的抑制之间的相关性,但对H+摄取到隔离的膜结构域没有抑制作用。当条件有利于离域的δμH+耦合模式时,较少的氯丙嗪与CFo结构结合,并且大量的H+离子在腔中积累。这些数据支持以下假设:Ca2+离子与8 kDa CF0蛋白(可能还有另一种蛋白,6 kDa多肽?)协同作用,形成一种门控机制,用于调节局部或离域耦合模式之间能量耦合H+梯度的表达。